首页 > 最新文献

Korean Journal of Pain最新文献

英文 中文
Neuropathic pain feature in cancer-induced bone pain: does it matter? a prospective observational study. 癌性骨痛的神经性疼痛特征:重要吗?一项前瞻性观察研究。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22392
Nantthasorn Zinboonyahgoon, Choopong Luansritisakul

Background: Cancer-induced bone pain (CIBP) is considered to have both nociceptive and neuropathic components. However, the prevalence, risk factors, and impact of the neuropathic components are yet poorly understood.

Methods: We estimate the prevalence of neuropathic pain (NP) features in patients with CIBP at a tertiary care pain clinic setting using the Douleur Neuropathique 4 questionnaire and evaluate their associated factors and their impact after 4 weeks of treatment using the Brief Pain Inventory questionnaire and the Edmonton Symptom Assessment System.

Results: A total of 133 patients were recruited. The estimated prevalence of NP was 30.8% (95% confidence interval: 23.6%-39.1%). Initially, the patients with NP had significantly higher average pain scores (6.00 vs. 5.05, P = 0.006), higher total interference scores (5.84 vs. 4.89, P = 0.033), and symptom distress scores (35.88 vs. 26.52, P = 0.002). After 4 weeks of treatment, patients in both groups reported significantly decreased pain intensity and improved quality of life. However, the patients with NP still reported significantly higher average pain (4.61 vs. 3.58, P = 0.048), trending toward higher total interference scores (3.52 vs. 2.99, P = 0.426), and symptom distress scores (23.30 vs. 20.77, P = 0.524). From multivariate analysis, the independent risk factors for NP were younger age, pain in the extremities, and higher average pain scores.

Conclusions: NP are common in patients with CIBP. These conditions negatively affect pain intensity and the patient's quality of life before and after treatment.

背景:癌症性骨痛(CIBP)被认为同时具有伤害性和神经性成分。然而,患病率、危险因素和神经病变成分的影响尚不清楚。方法:我们使用Douleur neuropathque 4问卷评估三级疼痛诊所CIBP患者神经性疼痛(NP)特征的患病率,并在治疗4周后使用简短疼痛量表问卷和埃德蒙顿症状评估系统评估其相关因素及其影响。结果:共纳入133例患者。NP的估计患病率为30.8%(95%可信区间:23.6%-39.1%)。最初,NP患者的平均疼痛评分(6.00比5.05,P = 0.006)、总干扰评分(5.84比4.89,P = 0.033)和症状困扰评分(35.88比26.52,P = 0.002)均显著高于对照组。治疗4周后,两组患者均报告疼痛强度显著降低,生活质量显著改善。然而,NP患者的平均疼痛(4.61比3.58,P = 0.048)、总干扰评分(3.52比2.99,P = 0.426)和症状困扰评分(23.30比20.77,P = 0.524)均显著高于NP患者。多因素分析显示,NP的独立危险因素为年龄较小、四肢疼痛和平均疼痛评分较高。结论:NP在CIBP患者中常见。这些情况对疼痛强度和患者治疗前后的生活质量产生负面影响。
{"title":"Neuropathic pain feature in cancer-induced bone pain: does it matter? a prospective observational study.","authors":"Nantthasorn Zinboonyahgoon,&nbsp;Choopong Luansritisakul","doi":"10.3344/kjp.22392","DOIUrl":"https://doi.org/10.3344/kjp.22392","url":null,"abstract":"<p><strong>Background: </strong>Cancer-induced bone pain (CIBP) is considered to have both nociceptive and neuropathic components. However, the prevalence, risk factors, and impact of the neuropathic components are yet poorly understood.</p><p><strong>Methods: </strong>We estimate the prevalence of neuropathic pain (NP) features in patients with CIBP at a tertiary care pain clinic setting using the Douleur Neuropathique 4 questionnaire and evaluate their associated factors and their impact after 4 weeks of treatment using the Brief Pain Inventory questionnaire and the Edmonton Symptom Assessment System.</p><p><strong>Results: </strong>A total of 133 patients were recruited. The estimated prevalence of NP was 30.8% (95% confidence interval: 23.6%-39.1%). Initially, the patients with NP had significantly higher average pain scores (6.00 vs. 5.05, <i>P</i> = 0.006), higher total interference scores (5.84 vs. 4.89, <i>P</i> = 0.033), and symptom distress scores (35.88 vs. 26.52, <i>P</i> = 0.002). After 4 weeks of treatment, patients in both groups reported significantly decreased pain intensity and improved quality of life. However, the patients with NP still reported significantly higher average pain (4.61 vs. 3.58, <i>P</i> = 0.048), trending toward higher total interference scores (3.52 vs. 2.99, <i>P</i> = 0.426), and symptom distress scores (23.30 vs. 20.77, <i>P</i> = 0.524). From multivariate analysis, the independent risk factors for NP were younger age, pain in the extremities, and higher average pain scores.</p><p><strong>Conclusions: </strong>NP are common in patients with CIBP. These conditions negatively affect pain intensity and the patient's quality of life before and after treatment.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"253-267"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/0a/kjp-36-2-253.PMC10043784.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9227877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of three different exercise trainings in patients with chronic neck pain: a randomized controlled study. 慢性颈部疼痛患者三种不同运动训练的比较:一项随机对照研究。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22371
Besta Hazal Gumuscu, Eylul Pinar Kisa, Begum Kara Kaya, Rasmi Muammer

Background: Neck pain is a common problem in the general population and second only to low back pain in musculoskeletal problems. The aim of this study is to compare three different types of exercise training in patients with chronic neck pain.

Methods: This study was conducted on 45 patients with neck pain. Patients were divided into 3 groups: Group 1 (conventional treatment), Group 2 (conventional treatment plus deep cervical flexor training), and Group 3 (conventional treatment plus stabilization of the neck and core region). The exercise programs were applied for four weeks, three days a week. The demographic data, pain intensity (verbal numeric pain scale), posture (Reedco's posture scale), cervical range of motion ([ROM] goniometer), and disability (Neck Disability Index [NDI]) were evaluated.

Results: In all groups, a significant improvement was found in terms of pain, posture, ROM, and NDI values in all groups (P < 0.001). Between the groups, analyses showed that the pain and posture improved more in Group 3, while the ROM and NDI improved more in Group 2.

Conclusions: In addition to conventional treatment, applying core stabilization exercises or deep cervical flexor muscle training to patients with neck pain may be more effective in reducing pain and disability and increasing ROM than conventional treatment alone.

背景:颈部疼痛是普通人群的常见问题,在肌肉骨骼问题中仅次于腰痛。本研究的目的是比较三种不同类型的运动训练对慢性颈部疼痛患者的影响。方法:对45例颈部疼痛患者进行研究。患者分为3组:1组(常规治疗)、2组(常规治疗+颈深屈肌训练)、3组(常规治疗+颈部及核心区稳定)。这些锻炼计划持续了四周,每周三天。评估患者的人口统计学数据、疼痛强度(口头数字疼痛量表)、姿势(Reedco姿势量表)、颈椎活动度(ROM)和残疾(颈部残疾指数[NDI])。结果:在所有组中,所有组在疼痛、姿势、ROM和NDI值方面均有显著改善(P < 0.001)。在两组之间,分析显示第三组疼痛和姿势改善更多,而第二组的ROM和NDI改善更多。结论:除常规治疗外,对颈部疼痛患者应用核心稳定练习或深颈椎屈肌训练可能比单独使用常规治疗更有效地减轻疼痛和残疾,并增加ROM。
{"title":"Comparison of three different exercise trainings in patients with chronic neck pain: a randomized controlled study.","authors":"Besta Hazal Gumuscu,&nbsp;Eylul Pinar Kisa,&nbsp;Begum Kara Kaya,&nbsp;Rasmi Muammer","doi":"10.3344/kjp.22371","DOIUrl":"https://doi.org/10.3344/kjp.22371","url":null,"abstract":"<p><strong>Background: </strong>Neck pain is a common problem in the general population and second only to low back pain in musculoskeletal problems. The aim of this study is to compare three different types of exercise training in patients with chronic neck pain.</p><p><strong>Methods: </strong>This study was conducted on 45 patients with neck pain. Patients were divided into 3 groups: Group 1 (conventional treatment), Group 2 (conventional treatment plus deep cervical flexor training), and Group 3 (conventional treatment plus stabilization of the neck and core region). The exercise programs were applied for four weeks, three days a week. The demographic data, pain intensity (verbal numeric pain scale), posture (Reedco's posture scale), cervical range of motion ([ROM] goniometer), and disability (Neck Disability Index [NDI]) were evaluated.</p><p><strong>Results: </strong>In all groups, a significant improvement was found in terms of pain, posture, ROM, and NDI values in all groups (<i>P</i> < 0.001). Between the groups, analyses showed that the pain and posture improved more in Group 3, while the ROM and NDI improved more in Group 2.</p><p><strong>Conclusions: </strong>In addition to conventional treatment, applying core stabilization exercises or deep cervical flexor muscle training to patients with neck pain may be more effective in reducing pain and disability and increasing ROM than conventional treatment alone.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"242-252"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/15/kjp-36-2-242.PMC10043788.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9196237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Long-term consistency of clinical sensory testing measures for pain assessment. 疼痛评估的临床感觉测试措施的长期一致性。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.23011
Pablo Bellosta-López, Víctor Doménech-García, Thorvaldur Skuli Palsson, Pablo Herrero, Steffan Wittrup Mcphee Christensen

Background: Understanding the stability of quantitative sensory tests (QSTs) over time is important to aid clinicians in selecting a battery of tests for assessing and monitoring patients. This study evaluated the short- and long-term reliability of selected QSTs.

Methods: Twenty healthy women participated in three experimental sessions: Baseline, 2 weeks, and 6 months. Measurements included pressure pain thresholds (PPT) in the neck, upper back, and leg; Pressure-cuff pain tolerance around the upper-arm; conditioned pain modulation during a pressure-cuff stimulus; and referred pain following a suprathreshold pressure stimulation. Intraclass correlation coefficients (ICC) and minimum detectable change (MDC) were calculated.

Results: Reliability for PPT was excellent for all sites at 2 weeks (ICC, 0.96-0.99; MDC, 22-55 kPa) and from good to excellent at 6 months (ICC, 0.88-0.95; MDC, 47-91 kPa). ICC for pressure-cuff pain tolerance indicated excellent reliability at both times (0.91-0.97). For conditioned pain modulation, reliability was moderate for all sites at 2 weeks (ICC, 0.57-0.74; MDC, 24%-35%), while it was moderate at the neck (ICC, 0.54; MDC, 27%) and poor at the upper back and leg at 6 months. ICC for referred pain areas was excellent at 2 weeks (0.90) and good at 6 months (0.86).

Conclusions: PPT, pressure pain tolerance, and pressure-induced referred pain should be considered reliable procedures to assess the pain-sensory profile over time. In contrast, conditioned pain modulation was shown to be unstable. Future studies prospectively analyzing the pain-sensory profile will be able to better calculate appropriate sample sizes.

背景:了解定量感觉试验(QSTs)随时间的稳定性对于帮助临床医生选择一组用于评估和监测患者的试验非常重要。本研究评估了所选qst的短期和长期可靠性。方法:20名健康女性参加了三个实验阶段:基线、2周和6个月。测量包括颈部、上背部和腿部的压力疼痛阈值(PPT);上臂周围压力袖带疼痛耐受力;压力袖带刺激时的条件性疼痛调节;以及阈上压力刺激后的牵涉性疼痛。计算了类内相关系数(ICC)和最小可检测变化(MDC)。结果:2周时PPT在所有部位的信度都很好(ICC, 0.96-0.99;MDC, 22-55 kPa), 6个月时从良好到优秀(ICC, 0.88-0.95;MDC, 47-91 kPa)。压力袖带疼痛耐受性的ICC在两次测试中均表现出极好的可靠性(0.91-0.97)。对于条理性疼痛调节,2周时所有部位的信度均为中等(ICC, 0.57-0.74;MDC, 24%-35%),而颈部适中(ICC, 0.54;MDC, 27%), 6个月时上背部和腿部较差。转介疼痛区域的ICC在2周(0.90)和6个月(0.86)时表现良好。结论:PPT、压力疼痛耐受性和压力诱发的转诊疼痛应该被认为是评估疼痛感觉的可靠方法。相反,条件疼痛调节被证明是不稳定的。未来的研究前瞻性地分析疼痛感觉档案将能够更好地计算适当的样本量。
{"title":"Long-term consistency of clinical sensory testing measures for pain assessment.","authors":"Pablo Bellosta-López,&nbsp;Víctor Doménech-García,&nbsp;Thorvaldur Skuli Palsson,&nbsp;Pablo Herrero,&nbsp;Steffan Wittrup Mcphee Christensen","doi":"10.3344/kjp.23011","DOIUrl":"https://doi.org/10.3344/kjp.23011","url":null,"abstract":"<p><strong>Background: </strong>Understanding the stability of quantitative sensory tests (QSTs) over time is important to aid clinicians in selecting a battery of tests for assessing and monitoring patients. This study evaluated the short- and long-term reliability of selected QSTs.</p><p><strong>Methods: </strong>Twenty healthy women participated in three experimental sessions: Baseline, 2 weeks, and 6 months. Measurements included pressure pain thresholds (PPT) in the neck, upper back, and leg; Pressure-cuff pain tolerance around the upper-arm; conditioned pain modulation during a pressure-cuff stimulus; and referred pain following a suprathreshold pressure stimulation. Intraclass correlation coefficients (ICC) and minimum detectable change (MDC) were calculated.</p><p><strong>Results: </strong>Reliability for PPT was excellent for all sites at 2 weeks (ICC, 0.96-0.99; MDC, 22-55 kPa) and from good to excellent at 6 months (ICC, 0.88-0.95; MDC, 47-91 kPa). ICC for pressure-cuff pain tolerance indicated excellent reliability at both times (0.91-0.97). For conditioned pain modulation, reliability was moderate for all sites at 2 weeks (ICC, 0.57-0.74; MDC, 24%-35%), while it was moderate at the neck (ICC, 0.54; MDC, 27%) and poor at the upper back and leg at 6 months. ICC for referred pain areas was excellent at 2 weeks (0.90) and good at 6 months (0.86).</p><p><strong>Conclusions: </strong>PPT, pressure pain tolerance, and pressure-induced referred pain should be considered reliable procedures to assess the pain-sensory profile over time. In contrast, conditioned pain modulation was shown to be unstable. Future studies prospectively analyzing the pain-sensory profile will be able to better calculate appropriate sample sizes.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"173-183"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/70/kjp-36-2-173.PMC10043786.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9227876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The analgesic effect of programmed cell death protein-1. 程序性细胞死亡蛋白-1的镇痛作用。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.23082
Jong Yeon Park
mental research paper about the heparanase and cancer pain progression was presented [1]. Heparanase treatment aggravated mechanical allodynia, cold response, and spontaneous pain. Additionally, the contents of inflammatory cytokines (TNF-α, NF-κB, IL-1β, and IL-6) was increased, and programmed death-ligand 1 (PD-L1) level was decreased in tumor tissue. Inversely, the heparanase inhibitor (SST0001) exhibited opposite results [1]. Programmed cell death protein 1, also known as PD-1, is a type I transmembrane glycoprotein and a cell surface receptor. PD-1 is broadly presented on cytotoxic T cells, regulatory T cells, B cells, natural killer cells, microglia, macrophages, and certain types of neurons [2–4]. PD-1 has a role in suppressing the inflammatory actions of T cells. Therefore, the immune system is downregulated, self-tolerance is promoted, autoimmune diseases are attenuated, and killing actions against cancer cells by the immune system could be prevented [5]. PD-1 is an essential and negatively acting regulator related to diverse biological effects and diseases, such as cancer immunotherapy, brain tumors, Alzheimer’s disease, stroke, multiple sclerosis and cognitive dysfunctions [6,7]. PD-1 signaling modulates synaptic plasticity, synaptic transmission, and neuronal excitability in neurons [2]. The neuronal signaling of PD-1 regulates pain by modulating dephosphorylating transient receptor potential subtype V1 (TRPV1) [8], GABAergic neurotransmission [4], and sodium/potassium channels [3]. In an experiment with Pd1 knockout mice, Pd1 knockout mice were more sensitive to pain stimulation than wild type mice, and it presented that PD-1 performs a crucial role in the modulation of pain [3]. Additionally, the activation of PD-1 signaling by PD-L1 is related to the regulations of μ-opioid receptor signals in the nociceptive neurons, and it enhances the antinociceptive actions of morphine [9]. Therefore, small molecular peptides targeting PD-1 could be an alternative medicine for treating chronic pain. On the other hand, PD-1 inhibitors, a newly developed class of anticancer medicine that block PD-1, could activate the immune system to attack cancer cells and could be used to treat special types of cancers [5]. For example, Pembrolizumab is a humanized IgG4 isotype antibody, and it blocks a protective mechanism of cancer cells and allows the immune system to destroy cancer cells. It targets the PD-1 receptor of lymphocytes and acts by targeting the cellular pathway of proteins, known as PD-1/PDL1, found on the immune cells and certain cancer cells. Pembrolizumab is used as an immunotherapy medicine
{"title":"The analgesic effect of programmed cell death protein-1.","authors":"Jong Yeon Park","doi":"10.3344/kjp.23082","DOIUrl":"https://doi.org/10.3344/kjp.23082","url":null,"abstract":"mental research paper about the heparanase and cancer pain progression was presented [1]. Heparanase treatment aggravated mechanical allodynia, cold response, and spontaneous pain. Additionally, the contents of inflammatory cytokines (TNF-α, NF-κB, IL-1β, and IL-6) was increased, and programmed death-ligand 1 (PD-L1) level was decreased in tumor tissue. Inversely, the heparanase inhibitor (SST0001) exhibited opposite results [1]. Programmed cell death protein 1, also known as PD-1, is a type I transmembrane glycoprotein and a cell surface receptor. PD-1 is broadly presented on cytotoxic T cells, regulatory T cells, B cells, natural killer cells, microglia, macrophages, and certain types of neurons [2–4]. PD-1 has a role in suppressing the inflammatory actions of T cells. Therefore, the immune system is downregulated, self-tolerance is promoted, autoimmune diseases are attenuated, and killing actions against cancer cells by the immune system could be prevented [5]. PD-1 is an essential and negatively acting regulator related to diverse biological effects and diseases, such as cancer immunotherapy, brain tumors, Alzheimer’s disease, stroke, multiple sclerosis and cognitive dysfunctions [6,7]. PD-1 signaling modulates synaptic plasticity, synaptic transmission, and neuronal excitability in neurons [2]. The neuronal signaling of PD-1 regulates pain by modulating dephosphorylating transient receptor potential subtype V1 (TRPV1) [8], GABAergic neurotransmission [4], and sodium/potassium channels [3]. In an experiment with Pd1 knockout mice, Pd1 knockout mice were more sensitive to pain stimulation than wild type mice, and it presented that PD-1 performs a crucial role in the modulation of pain [3]. Additionally, the activation of PD-1 signaling by PD-L1 is related to the regulations of μ-opioid receptor signals in the nociceptive neurons, and it enhances the antinociceptive actions of morphine [9]. Therefore, small molecular peptides targeting PD-1 could be an alternative medicine for treating chronic pain. On the other hand, PD-1 inhibitors, a newly developed class of anticancer medicine that block PD-1, could activate the immune system to attack cancer cells and could be used to treat special types of cancers [5]. For example, Pembrolizumab is a humanized IgG4 isotype antibody, and it blocks a protective mechanism of cancer cells and allows the immune system to destroy cancer cells. It targets the PD-1 receptor of lymphocytes and acts by targeting the cellular pathway of proteins, known as PD-1/PDL1, found on the immune cells and certain cancer cells. Pembrolizumab is used as an immunotherapy medicine","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"147-148"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/5f/kjp-36-2-147.PMC10043789.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9234577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of chronic pain and contributing factors: a cross-sectional population-based study among 2,379 Iranian adolescents. 慢性疼痛的患病率及其影响因素:2379名伊朗青少年的横断面人群研究
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22336
Maryam Shaygan, Azita Jaberi, Marziehsadat Razavizadegan, Zainab Shayegan

Background: This study aimed to determine the prevalence of chronic pain and its contributing factors among teenagers aged 12-21 years in Shiraz, Iran.

Methods: This cross-sectional study was conducted on adolescents aged 12-21 years. Demographic variables of the adolescents and their parents as well as the pain characteristics were assessed. Descriptive statistics, multinomial logistic regression, and regression models were used to describe the characteristics of the pain and its predictive factors.

Results: The prevalence of chronic pain was 23.7%. The results revealed no significant difference between the male and female participants regarding the pain characteristics, except for the home medications used for pain relief. The results of a chi-square test showed that the mother's pain, education, and occupation, and the father's education were associated significantly with chronic pain in adolescents (P < 0.05). Multinomial logistic regression also showed the mother's history of pain played a significant role in the incidence of adolescents' chronic pain.

Conclusions: The prevalence of chronic pain was relatively high in these adolescents. The results also provided basic and essential information about the contributing factors in this area. However, consideration of factors such as anxiety, depression, school problems, sleep, and physical activity are suggested in future longitudinal studies.

背景:本研究旨在确定伊朗设拉子地区12-21岁青少年慢性疼痛的患病率及其影响因素。方法:对12 ~ 21岁青少年进行横断面研究。评估青少年及其父母的人口学变量以及疼痛特征。采用描述性统计、多项逻辑回归和回归模型来描述疼痛的特征及其预测因素。结果:慢性疼痛发生率为23.7%。结果显示,除了用于缓解疼痛的家庭药物外,男性和女性参与者在疼痛特征方面没有显着差异。卡方检验结果显示,母亲疼痛程度、教育程度、职业、父亲教育程度与青少年慢性疼痛有显著相关(P < 0.05)。多项logistic回归也显示母亲疼痛史对青少年慢性疼痛的发生率有显著影响。结论:这些青少年慢性疼痛的患病率较高。研究结果还为该地区的影响因素提供了基本和必要的信息。然而,建议在未来的纵向研究中考虑诸如焦虑、抑郁、学校问题、睡眠和体育活动等因素。
{"title":"Prevalence of chronic pain and contributing factors: a cross-sectional population-based study among 2,379 Iranian adolescents.","authors":"Maryam Shaygan,&nbsp;Azita Jaberi,&nbsp;Marziehsadat Razavizadegan,&nbsp;Zainab Shayegan","doi":"10.3344/kjp.22336","DOIUrl":"https://doi.org/10.3344/kjp.22336","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to determine the prevalence of chronic pain and its contributing factors among teenagers aged 12-21 years in Shiraz, Iran.</p><p><strong>Methods: </strong>This cross-sectional study was conducted on adolescents aged 12-21 years. Demographic variables of the adolescents and their parents as well as the pain characteristics were assessed. Descriptive statistics, multinomial logistic regression, and regression models were used to describe the characteristics of the pain and its predictive factors.</p><p><strong>Results: </strong>The prevalence of chronic pain was 23.7%. The results revealed no significant difference between the male and female participants regarding the pain characteristics, except for the home medications used for pain relief. The results of a chi-square test showed that the mother's pain, education, and occupation, and the father's education were associated significantly with chronic pain in adolescents (<i>P</i> < 0.05). Multinomial logistic regression also showed the mother's history of pain played a significant role in the incidence of adolescents' chronic pain.</p><p><strong>Conclusions: </strong>The prevalence of chronic pain was relatively high in these adolescents. The results also provided basic and essential information about the contributing factors in this area. However, consideration of factors such as anxiety, depression, school problems, sleep, and physical activity are suggested in future longitudinal studies.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"230-241"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/b2/kjp-36-2-230.PMC10043785.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9234580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Feasibility and reliability of various morphologic features on magnetic resonance imaging for iliotibial band friction syndrome. 髂胫束摩擦综合征磁共振成像的各种形态学特征的可行性和可靠性。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22399
Jin Kyem Kim, Taeho Kim, Hong Seon Lee, Dong Kyu Kim

Background: To evaluate the feasibility, inter-reader reliability, and intra-reader reliability for various morphological features reported to be related to iliotibial band friction syndrome (ITBFS) on knee magnetic resonance imaging (MRI).

Methods: A total of 145 patients with a clinical diagnosis and knee MRI findings consistent with ITBFS were included in the "study group" and 232 patients without knee pathology on both physical examination and MRI were included in the "control group". Various morphologic features on knee MRI were assessed including the patella shape, patella height, lateral epicondyle anterior-posterior (AP) width, lateral epicondyle height, ITB diameter (ITB-d), and ITB area (ITB-a).

Results: Patients in the study group had significantly higher lateral epicondyle height (13.9 mm vs. 12.92 mm, P = 0.003), ITB-d (2.9 mm vs. 2.0 mm, P = 0.022), and ITB-a (38.5 mm2 vs. 23.8 mm2, P < 0.001) than the control group. ITB-a showed higher area under the curve index (0.849 with 74.1% sensitivity and 72.4% specificity at a 30.3 mm2 cutoff) than ITB-d (0.710 with 70.8% sensitivity and 61.2% specificity at 2.4 mm cutoff) and lateral epicondyle height (0.776 with 72.4% sensitivity and 67.8% specificity at 13.4 mm cutoff). However, only the interreader agreement for ITB-a (intraclass correlation coefficient = 0.65) was moderate, while the agreements for other morphologic features were good or excellent.

Conclusions: Lateral epicondyle height seems to be a reliable and feasible morphologic feature for diagnosis of ITBFS.

背景:评估膝关节磁共振成像(MRI)上与髂胫束摩擦综合征(ITBFS)相关的各种形态特征的可行性、读写器间可靠性和读写器内可靠性。方法:145例临床诊断及膝关节MRI表现符合ITBFS的患者作为“研究组”,232例体检及MRI均无膝关节病理的患者作为“对照组”。评估膝关节MRI上的各种形态学特征,包括髌骨形状、髌骨高度、外侧上髁前后(AP)宽度、外侧上髁高度、内侧胫束直径(ITB-d)和内侧胫束面积(ITB-a)。结果:研究组患者外上髁高度(13.9 mm vs. 12.92 mm, P = 0.003)、ITB-d (2.9 mm vs. 2.0 mm, P = 0.022)、ITB-a (38.5 mm2 vs. 23.8 mm2, P < 0.001)均显著高于对照组。ITB-a曲线下面积指数(0.849,敏感性74.1%,特异性72.4%,30.3 mm2截止)高于ITB-d(0.710,敏感性70.8%,特异性61.2%,2.4 mm截止)和外上髁高度(0.776,敏感性72.4%,特异性67.8%,13.4 mm截止)。然而,只有ITB-a的解释器一致性为中等(类内相关系数= 0.65),而其他形态学特征的一致性为良好或极好。结论:外上髁高度是诊断ITBFS的可靠、可行的形态学特征。
{"title":"Feasibility and reliability of various morphologic features on magnetic resonance imaging for iliotibial band friction syndrome.","authors":"Jin Kyem Kim,&nbsp;Taeho Kim,&nbsp;Hong Seon Lee,&nbsp;Dong Kyu Kim","doi":"10.3344/kjp.22399","DOIUrl":"https://doi.org/10.3344/kjp.22399","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the feasibility, inter-reader reliability, and intra-reader reliability for various morphological features reported to be related to iliotibial band friction syndrome (ITBFS) on knee magnetic resonance imaging (MRI).</p><p><strong>Methods: </strong>A total of 145 patients with a clinical diagnosis and knee MRI findings consistent with ITBFS were included in the \"study group\" and 232 patients without knee pathology on both physical examination and MRI were included in the \"control group\". Various morphologic features on knee MRI were assessed including the patella shape, patella height, lateral epicondyle anterior-posterior (AP) width, lateral epicondyle height, ITB diameter (ITB-d), and ITB area (ITB-a).</p><p><strong>Results: </strong>Patients in the study group had significantly higher lateral epicondyle height (13.9 mm <i>vs.</i> 12.92 mm, <i>P</i> = 0.003), ITB-d (2.9 mm <i>vs.</i> 2.0 mm, <i>P</i> = 0.022), and ITB-a (38.5 mm<sup>2</sup> <i>vs.</i> 23.8 mm<sup>2</sup>, <i>P</i> < 0.001) than the control group. ITB-a showed higher area under the curve index (0.849 with 74.1% sensitivity and 72.4% specificity at a 30.3 mm<sup>2</sup> cutoff) than ITB-d (0.710 with 70.8% sensitivity and 61.2% specificity at 2.4 mm cutoff) and lateral epicondyle height (0.776 with 72.4% sensitivity and 67.8% specificity at 13.4 mm cutoff). However, only the interreader agreement for ITB-a (intraclass correlation coefficient = 0.65) was moderate, while the agreements for other morphologic features were good or excellent.</p><p><strong>Conclusions: </strong>Lateral epicondyle height seems to be a reliable and feasible morphologic feature for diagnosis of ITBFS.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"208-215"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/a1/kjp-36-2-208.PMC10043787.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9201815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ultrasound-guided PENG block versus intraarticular corticosteroid injection in hip osteoarthritis: a randomised controlled study. 超声引导的彭阻滞与关节内皮质类固醇注射治疗髋关节骨关节炎:一项随机对照研究
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22325
Selin Guven Kose, Halil Cihan Kose, Feyza Celikel, Serkan Tulgar, Omer Taylan Akkaya

Background: This study aimed to compare the effectiveness of the pericapsular nerve group (PENG) block and intra-articular injection (IAI) of steroid-bupivacaine in the treatment of hip osteoarthritis (OA).

Methods: After randomization, patients received either a PENG block or IAI under ultrasound-guidance. Clinical evaluations were recorded at baseline, day 1, and weeks 1, 4, and 8 post-intervention. The numerical rating scale (NRS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), Harris Hip Scale (HHS) scores, pain medication use determined by a quantitative analgesic questionnaire, and patient satisfaction were evaluated.

Results: Sixty patients were included in this study. NRS scores improved significantly for both groups during the follow-up compared to pretreatment (P < 0.001), with better pain scores for the PENG group (P < 0.001) at day 1 with larger effect size (Cohen's d = 4.62), and IAI group at 4 (Cohen's d = 5.15) and 8 (Cohen's d = 4.33) weeks (P < 0.001). There was no significant difference in pain medication consumption (P = 0.499) and patient satisfaction (P = 0.138) between groups. Patients in the IAI group experienced significant improvement in HHS (Cohen's d = 2.16, P = 0.007) and WOMAC (Cohen's d = 1.02, P = 0.036) scores at 8 weeks compared to the PENG group.

Conclusions: The ultrasound-guided PENG block provides effective pain relief which improves functionality and quality of life in hip OA patients up to 2 months. The PENG block can be considered an easy, safe, and useful alternative treatment modality for hip OA.

背景:本研究旨在比较包膜神经组(PENG)阻滞和关节内注射(IAI)类固醇布比卡因治疗髋关节骨性关节炎(OA)的疗效。方法:随机分组后,患者在超声引导下接受PENG阻滞或IAI。在基线、干预后第1天、第1周、第4周和第8周记录临床评估。评估数值评定量表(NRS)、西安大略省和麦克马斯特大学关节炎指数(WOMAC)、哈里斯髋关节量表(HHS)评分、定量镇痛问卷确定的止痛药使用情况以及患者满意度。结果:60例患者纳入本研究。随访期间,两组患者的NRS评分均较治疗前显著提高(P < 0.001),彭组患者在第1天疼痛评分较好(P < 0.001),效应量较大(Cohen’s d = 4.62), IAI组患者在第4周(Cohen’s d = 5.15)和第8周(Cohen’s d = 4.33) (P < 0.001)。两组患者止痛药用量(P = 0.499)和患者满意度(P = 0.138)差异无统计学意义。与PENG组相比,IAI组患者在8周时HHS (Cohen’s d = 2.16, P = 0.007)和WOMAC (Cohen’s d = 1.02, P = 0.036)评分显著改善。结论:超声引导的PENG阻滞可有效缓解疼痛,改善髋关节OA患者长达2个月的功能和生活质量。彭阻滞可以被认为是髋关节OA的一种简单、安全、有用的替代治疗方式。
{"title":"Ultrasound-guided PENG block <i>versus</i> intraarticular corticosteroid injection in hip osteoarthritis: a randomised controlled study.","authors":"Selin Guven Kose,&nbsp;Halil Cihan Kose,&nbsp;Feyza Celikel,&nbsp;Serkan Tulgar,&nbsp;Omer Taylan Akkaya","doi":"10.3344/kjp.22325","DOIUrl":"https://doi.org/10.3344/kjp.22325","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to compare the effectiveness of the pericapsular nerve group (PENG) block and intra-articular injection (IAI) of steroid-bupivacaine in the treatment of hip osteoarthritis (OA).</p><p><strong>Methods: </strong>After randomization, patients received either a PENG block or IAI under ultrasound-guidance. Clinical evaluations were recorded at baseline, day 1, and weeks 1, 4, and 8 post-intervention. The numerical rating scale (NRS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), Harris Hip Scale (HHS) scores, pain medication use determined by a quantitative analgesic questionnaire, and patient satisfaction were evaluated.</p><p><strong>Results: </strong>Sixty patients were included in this study. NRS scores improved significantly for both groups during the follow-up compared to pretreatment (<i>P</i> < 0.001), with better pain scores for the PENG group (<i>P</i> < 0.001) at day 1 with larger effect size (Cohen's d = 4.62), and IAI group at 4 (Cohen's d = 5.15) and 8 (Cohen's d = 4.33) weeks (<i>P</i> < 0.001). There was no significant difference in pain medication consumption (<i>P</i> = 0.499) and patient satisfaction (<i>P</i> = 0.138) between groups. Patients in the IAI group experienced significant improvement in HHS (Cohen's d = 2.16, <i>P</i> = 0.007) and WOMAC (Cohen's d = 1.02, <i>P</i> = 0.036) scores at 8 weeks compared to the PENG group.</p><p><strong>Conclusions: </strong>The ultrasound-guided PENG block provides effective pain relief which improves functionality and quality of life in hip OA patients up to 2 months. The PENG block can be considered an easy, safe, and useful alternative treatment modality for hip OA.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"195-207"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/6c/kjp-36-2-195.PMC10043791.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9234579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Practical strategies for the prevention and management of chronic postsurgical pain. 预防和处理慢性术后疼痛的实用策略。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.23080
Bo Rim Kim, Soo-Hyuk Yoon, Ho-Jin Lee

Chronic postsurgical pain (CPSP) is a multifactorial condition that affects a significant proportion of patients undergoing surgery. The prevention and management of CPSP require the identification of preoperative risk factors to screen high-risk patients and establish appropriate perioperative pain management plans to prevent its development. Active postoperative pain management should be provided to prevent CPSP in patients with severe pain following surgery. These tasks have become important for perioperative team members in the management of CPSP. This review article provides a comprehensive overview of the latest research on the role of perioperative team members in preventing and managing CPSP. Additionally, it highlights practical strategies that can be employed in clinical practice, covering the definition and risk factors for CPSP, including preoperative, intraoperative, and postoperative factors, as well as a risk prediction model. The article also explores various treatments for CPSP, as well as preventive measures, including preemptive analgesia, regional anesthesia, pharmacological interventions, psychoeducational support, and surgical technique modification. This article emphasizes the importance of a comprehensive perioperative pain management plan that includes multidisciplinary interventions, using the transitional pain service as an example. By adopting a multidisciplinary and collaborative approach, perioperative team members can improve patient outcomes, enhance patient satisfaction, and reduce healthcare costs. However, further research is necessary to establish targeted interventions to effectively prevent and manage CPSP.

慢性术后疼痛(CPSP)是一种多因素的疾病,影响了很大一部分接受手术的患者。预防和管理CPSP需要识别术前危险因素,筛选高危患者,并制定相应的围手术期疼痛管理计划,防止其发展。应提供积极的术后疼痛管理,以防止术后严重疼痛的患者发生CPSP。这些任务已成为围手术期团队成员在CPSP管理中的重要任务。本文综述了围手术期团队成员在预防和管理CPSP中的作用的最新研究。此外,它还强调了可用于临床实践的实用策略,涵盖了CPSP的定义和危险因素,包括术前,术中和术后因素,以及风险预测模型。文章还探讨了CPSP的各种治疗方法和预防措施,包括先发制人的镇痛、区域麻醉、药物干预、心理教育支持和手术技术改进。这篇文章强调了一个全面的围手术期疼痛管理计划的重要性,包括多学科干预,以过渡疼痛服务为例。通过采用多学科和协作的方法,围手术期团队成员可以改善患者预后,提高患者满意度,并降低医疗成本。然而,需要进一步研究建立有针对性的干预措施,以有效预防和管理CPSP。
{"title":"Practical strategies for the prevention and management of chronic postsurgical pain.","authors":"Bo Rim Kim,&nbsp;Soo-Hyuk Yoon,&nbsp;Ho-Jin Lee","doi":"10.3344/kjp.23080","DOIUrl":"https://doi.org/10.3344/kjp.23080","url":null,"abstract":"<p><p>Chronic postsurgical pain (CPSP) is a multifactorial condition that affects a significant proportion of patients undergoing surgery. The prevention and management of CPSP require the identification of preoperative risk factors to screen high-risk patients and establish appropriate perioperative pain management plans to prevent its development. Active postoperative pain management should be provided to prevent CPSP in patients with severe pain following surgery. These tasks have become important for perioperative team members in the management of CPSP. This review article provides a comprehensive overview of the latest research on the role of perioperative team members in preventing and managing CPSP. Additionally, it highlights practical strategies that can be employed in clinical practice, covering the definition and risk factors for CPSP, including preoperative, intraoperative, and postoperative factors, as well as a risk prediction model. The article also explores various treatments for CPSP, as well as preventive measures, including preemptive analgesia, regional anesthesia, pharmacological interventions, psychoeducational support, and surgical technique modification. This article emphasizes the importance of a comprehensive perioperative pain management plan that includes multidisciplinary interventions, using the transitional pain service as an example. By adopting a multidisciplinary and collaborative approach, perioperative team members can improve patient outcomes, enhance patient satisfaction, and reduce healthcare costs. However, further research is necessary to establish targeted interventions to effectively prevent and manage CPSP.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"149-162"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/db/kjp-36-2-149.PMC10043790.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9234578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A comparison of analgesic efficacy and safety of clonidine and methylprednisolone as additives to 0.25% ropivacaine in stellate ganglion block for the treatment of complex regional pain syndrome: a prospective randomised single blind study. 星状神经节阻滞中添加0.25%罗哌卡因治疗复杂局部疼痛综合征时,可拉定和甲基强的松龙的镇痛疗效和安全性比较:一项前瞻性随机单盲研究。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22299
Sreyashi Naskar, Debesh Bhoi, Heena Garg, Maya Dehran, Anjan Trikha, Mohammed Tahir Ansari

Background: The role of the sympathetic nervous system appears to be central in causing pain in complex regional pain syndrome (CRPS). The stellate ganglion block (SGB) using additives with local anesthetics is an established treatment modality. However, literature is sparse in support of selective benefits of different additives for SGB. Hence, the authors aimed to compare the efficacy and safety of clonidine with methylprednisolone as additives to ropivacaine in the SGB for treatment of CRPS.

Methods: A prospective randomized single blinded study (the investigator blinded to the study groups) was conducted among patients with CRPS-I of the upper limb, aged 18-70 years with American Society of Anaesthesiologists physical status I-III. Clonidine (15 μg) and methylprednisolone (40 mg) were compared as additives to 0.25% ropivacaine (5 mL) for SGB. After medical treatment for two weeks, patients in each of the two groups were given seven ultrasound guided SGBs on alternate days.

Results: There was no significant difference between the two groups with respect to visual analogue scale score, edema, or overall patient satisfaction. After 1.5 months follow-up, however, the group that received methylprednisolone had better improvement in range of motion. No significant side effects were seen with either drug.

Conclusions: The use of additives, both methylprednisolone and clonidine, is safe and effective for the SGB in CRPS. The significantly better improvement in joint mobility with methylprednisolone suggests that it should be considered promising as an additive to local anaesthetics when joint mobility is the concern.

背景:交感神经系统在复杂区域性疼痛综合征(CRPS)中起着中心作用。星状神经节阻滞(SGB)使用添加剂与局部麻醉剂是一种既定的治疗方式。然而,文献很少支持不同添加剂对SGB的选择性效益。因此,作者旨在比较可乐定与甲基强的松龙作为罗哌卡因在SGB中治疗CRPS的疗效和安全性。方法:采用前瞻性随机单盲研究(研究者对研究组不设盲法),选取年龄18 ~ 70岁、美国麻醉医师学会身体状况I-III级的上肢CRPS-I型患者。将可乐定(15 μg)和甲基强的松龙(40 mg)作为SGB 0.25%罗哌卡因(5 mL)的添加剂进行比较。治疗两周后,两组患者隔天分别给予7次超声引导下的sbg。结果:两组在视觉模拟量表评分、水肿或总体患者满意度方面无显著差异。然而,经过1.5个月的随访,接受甲基强的松龙治疗的组在活动范围方面有更好的改善。两种药物均未见明显副作用。结论:使用甲基强的松龙和可乐定治疗CRPS的SGB是安全有效的。甲基强的松龙对关节活动的显著改善表明,当关节活动受到关注时,它应该被认为是一种有希望的局部麻醉剂的添加剂。
{"title":"A comparison of analgesic efficacy and safety of clonidine and methylprednisolone as additives to 0.25% ropivacaine in stellate ganglion block for the treatment of complex regional pain syndrome: a prospective randomised single blind study.","authors":"Sreyashi Naskar,&nbsp;Debesh Bhoi,&nbsp;Heena Garg,&nbsp;Maya Dehran,&nbsp;Anjan Trikha,&nbsp;Mohammed Tahir Ansari","doi":"10.3344/kjp.22299","DOIUrl":"https://doi.org/10.3344/kjp.22299","url":null,"abstract":"<p><strong>Background: </strong>The role of the sympathetic nervous system appears to be central in causing pain in complex regional pain syndrome (CRPS). The stellate ganglion block (SGB) using additives with local anesthetics is an established treatment modality. However, literature is sparse in support of selective benefits of different additives for SGB. Hence, the authors aimed to compare the efficacy and safety of clonidine with methylprednisolone as additives to ropivacaine in the SGB for treatment of CRPS.</p><p><strong>Methods: </strong>A prospective randomized single blinded study (the investigator blinded to the study groups) was conducted among patients with CRPS-I of the upper limb, aged 18-70 years with American Society of Anaesthesiologists physical status I-III. Clonidine (15 μg) and methylprednisolone (40 mg) were compared as additives to 0.25% ropivacaine (5 mL) for SGB. After medical treatment for two weeks, patients in each of the two groups were given seven ultrasound guided SGBs on alternate days.</p><p><strong>Results: </strong>There was no significant difference between the two groups with respect to visual analogue scale score, edema, or overall patient satisfaction. After 1.5 months follow-up, however, the group that received methylprednisolone had better improvement in range of motion. No significant side effects were seen with either drug.</p><p><strong>Conclusions: </strong>The use of additives, both methylprednisolone and clonidine, is safe and effective for the SGB in CRPS. The significantly better improvement in joint mobility with methylprednisolone suggests that it should be considered promising as an additive to local anaesthetics when joint mobility is the concern.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"216-229"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/5f/kjp-36-2-216.PMC10043792.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9196234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effectiveness of percutaneous epidural neuroplasty using a balloon catheter in patients with chronic spinal stenosis accompanying mild spondylolisthesis: a longitudinal cohort study. 使用球囊导管经皮硬膜外神经成形术治疗慢性椎管狭窄伴轻度脊柱滑脱患者的有效性:一项纵向队列研究。
IF 2.8 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2023-04-01 DOI: 10.3344/kjp.22289
Myong-Hwan Karm, Chan-Sik Kim, Doo-Hwan Kim, Dongreul Lee, Youngmu Kim, Jin-Woo Shin, Seong-Soo Choi

Background: Degenerative lumbar spondylolisthesis (DLS) is frequently associated with lumbar spinal stenosis (LSS) and conservative treatments such as epidural steroid injection do not have long-term benefits in LSS patients with DLS. This study evaluated the effectiveness of percutaneous epidural neuroplasty using a balloon catheter in patients with LSS and DLS.

Methods: Patients' sex, age, body mass index, diabetes, hypertension, stenosis grading, pain duration, location, pain intensity, and medications were retrieved from electronic medical records. At 1, 3, and 6 months following the procedure, data on pain severity, medication usage, and physical functional status were analyzed. A generalized estimating equations model was used at the six-month follow-up. Patients were divided into those with DLS (the spondylolisthesis group) and those without DLS (the no spondylolisthesis group) to evaluate whether the effects of percutaneous epidural neuroplasty using a balloon catheter were different.

Results: A total of 826 patients were included (spondylolisthesis: 433 patients, 52.4%; no spondylolisthesis: 393 patients, 47.6%). Age, body mass index, hypertension, pain location, and stenosis grading were statistically different between the two groups. The generalized estimating equations analyses with unadjusted and adjusted estimation revealed a significant improvement in the estimated mean numerical rating scale of pain intensities compared to that at baseline in both groups (P < 0.001). Any adverse events that occurred were minor and temporary.

Conclusions: Percutaneous epidural neuroplasty using a balloon catheter may be an alternative treatment option for patients with chronic LSS, regardless of accompanying DLS, who have had failed conservative management.

背景:退行性腰椎滑脱(DLS)通常与腰椎管狭窄(LSS)相关,保守治疗如硬膜外类固醇注射对LSS合并DLS的患者没有长期益处。本研究评估了使用球囊导管经皮硬膜外神经成形术治疗LSS和DLS患者的有效性。方法:从电子病历中检索患者的性别、年龄、体重指数、糖尿病、高血压、狭窄分级、疼痛持续时间、部位、疼痛强度和用药情况。在手术后1、3和6个月,分析疼痛严重程度、药物使用和身体功能状态的数据。6个月随访时采用广义估计方程模型。将患者分为有DLS组(椎体滑脱组)和无DLS组(无椎体滑脱组),以评价球囊导管经皮硬膜外神经成形术的效果是否不同。结果:共纳入826例患者(脊柱滑脱433例,占52.4%;无脊柱滑脱:393例(47.6%)。两组患者年龄、体重指数、高血压、疼痛部位、狭窄分级差异均有统计学意义。未经调整和调整估计的广义估计方程分析显示,与基线相比,两组的估计疼痛强度的平均数值评定量表有显著改善(P < 0.001)。发生的任何不良事件都是轻微和暂时的。结论:使用球囊导管的经皮硬膜外神经成形术可能是慢性LSS患者的另一种治疗选择,无论是否伴有DLS,保守治疗失败。
{"title":"Effectiveness of percutaneous epidural neuroplasty using a balloon catheter in patients with chronic spinal stenosis accompanying mild spondylolisthesis: a longitudinal cohort study.","authors":"Myong-Hwan Karm,&nbsp;Chan-Sik Kim,&nbsp;Doo-Hwan Kim,&nbsp;Dongreul Lee,&nbsp;Youngmu Kim,&nbsp;Jin-Woo Shin,&nbsp;Seong-Soo Choi","doi":"10.3344/kjp.22289","DOIUrl":"https://doi.org/10.3344/kjp.22289","url":null,"abstract":"<p><strong>Background: </strong>Degenerative lumbar spondylolisthesis (DLS) is frequently associated with lumbar spinal stenosis (LSS) and conservative treatments such as epidural steroid injection do not have long-term benefits in LSS patients with DLS. This study evaluated the effectiveness of percutaneous epidural neuroplasty using a balloon catheter in patients with LSS and DLS.</p><p><strong>Methods: </strong>Patients' sex, age, body mass index, diabetes, hypertension, stenosis grading, pain duration, location, pain intensity, and medications were retrieved from electronic medical records. At 1, 3, and 6 months following the procedure, data on pain severity, medication usage, and physical functional status were analyzed. A generalized estimating equations model was used at the six-month follow-up. Patients were divided into those with DLS (the spondylolisthesis group) and those without DLS (the no spondylolisthesis group) to evaluate whether the effects of percutaneous epidural neuroplasty using a balloon catheter were different.</p><p><strong>Results: </strong>A total of 826 patients were included (spondylolisthesis: 433 patients, 52.4%; no spondylolisthesis: 393 patients, 47.6%). Age, body mass index, hypertension, pain location, and stenosis grading were statistically different between the two groups. The generalized estimating equations analyses with unadjusted and adjusted estimation revealed a significant improvement in the estimated mean numerical rating scale of pain intensities compared to that at baseline in both groups (P < 0.001). Any adverse events that occurred were minor and temporary.</p><p><strong>Conclusions: </strong>Percutaneous epidural neuroplasty using a balloon catheter may be an alternative treatment option for patients with chronic LSS, regardless of accompanying DLS, who have had failed conservative management.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":"36 2","pages":"184-194"},"PeriodicalIF":2.8,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/e0/kjp-36-2-184.PMC10043794.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9207190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Korean Journal of Pain
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1